国家卫生健康委昨日明确，"轻医美"属于医疗行为，严禁生活美容机构违规开展。当前一些商家利 用"容貌焦虑"非法培训、无证操作，导致伤害事件频发。公众应选择正规医疗机构，警惕"速成班"话 术，发现线索可举报。 爱美之心碰上美丽陷阱 究竟什么才是"轻医美"？国家卫健委给出了清晰界定：它本质是医疗行为。所谓"轻医美"，通常指利用 注射、光电、生物技术等方式进行的非手术类医疗美容项目，其核心前提是必须在取得《医疗机构执业 许可证》的医疗美容机构内开展，且操作者必须是持有相关资质的专业医师或护士。这意味着，我们日 常生活中熟悉的美容院、美发店、美甲店、养生会所等生活类美容机构，其服务范围仅限于皮肤表面清 洁、护理、修饰等非侵入性项目，严禁开展任何破皮、注入或使用医疗器械的"轻医美"项目。 公众切勿因价格诱惑或熟人介绍，而在这些场所接受所谓的"轻医美"服务，将自身健康置于巨大风险之 中。 别让速成班毁了你的脸 想要悄悄变美，却可能踏入危险陷阱。近年来，打着"无创""恢复快"招牌的"轻医美"项目风靡大街小 巷，从热玛吉、水光针到少女针，吸引着众多求美者。然而，这股热潮背后却乱象丛生。 国家卫生健康委在昨天召开的新闻发布会上指 ...

2月10日，国家卫生健康委召开新闻发布会，对医疗美容行业中的"轻医美"乱象发出明确警示。近年 来，以注射、激光为代表的非手术类医美项目备受追捧，但部分不良商家借机制造"容貌焦虑"，隐瞒医 疗风险，更在不具备资质的情况下非法开办"轻医美速成班"，导致学员互扎致伤事件频发，给求美者带 来严重健康威胁。 国家卫生健康委强调，"轻医美"本质是医疗行为，必须由持证医务人员在正规医疗机构内操作。生活美 容店、美甲店等场所严禁开展此类项目。同时，社会上流传的"三天学会打针""零基础速成"等培训，往 往涉及非法行医、使用假药劣械、颁发虚假证书等多重违法问题。此外，发布会上，多位专家结合节气 和春节特点，围绕流感防护、春季养生、体重管理等公众健康关切展开全面解读。 严禁生活类美容机构开展"轻医美"项目 "轻医美"是指通过非手术或微创的医学美容手段，实现皮肤护理、抗衰、塑形等美容效果的医美项目， 具有恢复期短、风险相对较低的特点。常见的轻医美项目包括水光针、玻尿酸注射、光子嫩肤等。 据王大燕介绍，当前全国流感疫情总体处于低流行水平，近两月持续下降，流行毒株以甲型H3N2亚型 为主要流行株，乙型Victoria系占比缓慢上升。此外 ...

二，炉边漫谈 毫无疑问，上周五美国财政部长对于美联储降息缩表的一番解释，大大缓解了市场的焦虑，而这也是今天全球股市暴涨的原因所在，那么这段话究竟是什么 意思呢？ 先说说「美联储的定心丸」：别慌，不会急着缩表 一，今日要点 今天沪指上演红周一，蛇年股市还有最后四个交易日，是否就此开启春节红包行情呢？ 最近市场不是揪着美联储换主席的事儿焦虑嘛？担心沃什上台后会不会「政策急转弯」、急着缩表抽流动性。结果美国财长贝森特出来「灭火」了：就算沃 什当主席（这家伙之前还批评过美联储买债券呢），也不会马上动手缩表；而且沃什会很独立，美联储可能得花一整年才会决定资产负债表的事儿。 其实市场怕的就是「突然收紧」——毕竟缩表意味着流动性变少，资金成本会涨。贝森特这话本质是安抚情绪，但说到底，美联储真要怎么做，还是得看资 金怎么解读：要是资金觉得「缩表节奏慢」，就敢放心进场；要是觉得「口说无凭」，照样会用脚投票。 再聊聊「特斯拉的光伏野心」：中国产业链要吃肉了 特斯拉又搞大动作——要扩大太阳能电池制造，三年目标冲100吉瓦！更关键的是：全球光伏产业链中国占绝对优势，马斯克就算想搞「太空光伏」（航 天、太空算力的能源核心），也绕不开中 ...

节前医美进入"拉满模式"：启动更早、客流更密 "今年忙得特别早。"这是多位医美从业者对今年春节前市场的直观判断。 "元旦假期前就已经明显忙起来了，连喝口水的时间都没有。"西安国际医学中心医院整形美容 科主任孙峰向财联社记者表示，其所在的眼整形门诊，一上午面诊人数最多能达到45人，"以 我个人的排期为例，一天四五台是常态，年前早就约满了，部分顾客的手术已经排至春节后 了。" 晚上九点，成都一家轻医美诊所的候诊区仍灯火通明。玻璃门外，商场人流已明显减少；玻璃 门内，取号屏上的数字却仍在滚动刷新，前台不时提醒，"后面的客人稍等几分钟。" 财联社记者近日通过调研、多方采访了解到，1月份以来，全国各地医美机构逐渐迎来客流高 峰期的同时，医美消费者的需求也在发生结构性变化。 从机构排期、门诊接诊量到营业时间延长，多项指标均显示，节前医美市场已提前进入"满负 荷运转"状态。多位医美机构负责人、整形科医生在接受财联社记者采访时表示， 今年节前医 美消费热潮启动时间明显早于往年，且客流高峰持续时间更长。 这场热潮并非单纯的周期性回暖，多位受访者表示， 轻医美项目取代传统手术类项目，成为节 前消费的绝对主流；项目选择更趋精准化、 ...

Core Insights - The medical beauty market is experiencing a surge in demand as consumers prepare for the upcoming Spring Festival, with many opting for aesthetic treatments to enhance their appearance [1][3]. Group 1: Market Trends - There has been a significant increase in user visits to medical beauty services, with Meituan reporting over a 15% year-on-year growth and nearly a 10% week-on-week increase [3]. - The demand for aesthetic treatments is primarily focused on anti-aging, wrinkle removal, and urgent skin condition improvement, with varying recovery periods influencing consumer choices [3]. - Popular treatments have shifted from longer recovery options like Thermage and Ultherapy to shorter recovery options such as hyaluronic acid injections and photorejuvenation [3]. Group 2: Company Initiatives - Meituan has launched a "Beautiful New Year" campaign, offering a 3000 yuan medical beauty voucher package and a beauty calendar to help users select appropriate treatments based on recovery times [3]. - During the Spring Festival, at least 30% of medical beauty institutions on the Meituan platform will remain open, which is a 5% increase compared to the previous year, providing convenience for users seeking urgent skin treatments [3]. - The company promotes the "Safe Beauty" initiative to ensure compliance and safety in the industry, aiming to verify over 12 million treatment instances by the end of 2025 across 2500 institutions in 140 cities [4].

Core Viewpoint - The pursuit of "facial rejuvenation" is becoming a focal point for the public, moving beyond superficial beauty to emphasize health and natural integration, as discussed by Liu Pei, a deputy director at Shandong University Qilu Hospital's Department of Plastic Surgery and Burns [2] Group 1: Definition and Distinction - Facial rejuvenation is defined as a medical aesthetic concept that focuses on improving signs of aging such as wrinkles, skin laxity, and pigmentation through surgical or non-surgical interventions, aiming to restore a youthful and natural appearance [3] - Unlike facial rejuvenation, anti-aging encompasses a broader range of practices aimed at preventing or delaying aging, including skincare, regular routines, and dietary adjustments [3] - The concept of "frozen age" refers to the unrealistic expectation of halting aging signs entirely, while facial rejuvenation combines prevention and improvement tailored to individual conditions [3] Group 2: Popular Treatments and Suitability - Popular facial rejuvenation treatments include botulinum toxin injections (commonly known as "slim face injections") and water light injections, each with specific suitability criteria and contraindications [4] - The effectiveness of botulinum toxin injections is contingent upon the presence of hypertrophied masseter muscles, and the dosage must be personalized based on individual facial structure [5] - Water light injections are designed to combat skin dryness and dullness by delivering hyaluronic acid directly into the dermis, but post-treatment hydration is essential for optimal results [5] Group 3: Personalized Treatment Plans - Each facial rejuvenation plan must be customized, taking into account the individual's facial foundation, aging level, aesthetic needs, and lifestyle [6] - A thorough assessment of the patient's facial structure and health status is crucial to ensure targeted and safe treatment, avoiding a "one-size-fits-all" approach [6] - Patients are encouraged to have realistic expectations about aging, understanding that while it cannot be completely reversed, it can be delayed through scientific and professional medical interventions [6]

Core Insights - The medical beauty market is experiencing a surge in demand as consumers prepare for the upcoming Spring Festival, with many opting for aesthetic treatments to enhance their appearance [1][2]. Group 1: Market Trends - There is a notable shift in consumer behavior, with traditional beauty treatments being supplemented by light medical beauty procedures, forming a new "Spring Festival beauty package" [1]. - Meituan's data indicates a more than 15% year-on-year increase in user visits to medical beauty services, with a nearly 10% week-on-week growth, reflecting heightened market activity [1]. - The demand is primarily focused on anti-aging, wrinkle removal, and skin emergency treatments, with varying popularity based on recovery times [1]. Group 2: Treatment Popularity - Treatments like Thermage and Ultherapy peaked in early January but have seen a gradual decline, while hyaluronic acid, Botox, and photorejuvenation have been on the rise recently [1]. - Meituan has launched a "Beautiful New Year" campaign, offering a 3000 yuan medical beauty voucher package and a beauty calendar to help users choose suitable treatments [1]. Group 3: Operational Insights - During the Spring Festival, at least 30% of medical beauty institutions on the Meituan platform will remain open, an increase of about 5 percentage points from the previous year, providing convenience for users seeking treatments [2]. - Meituan is promoting the "Safe Beauty" initiative to ensure compliance and safety in the industry, aiming to have over 12 million verified treatments by the end of 2025, covering 2500 institutions across 140 cities [3].

Core Viewpoint - Four Seasons Pharmaceutical (0460.HK) has seen a significant stock price increase following the approval of new specifications for its self-developed polylactic acid facial filler, known as "Tongyan Needle," by the National Medical Products Administration of China [1][2] Group 1: Product Development - The newly approved specifications for the Tongyan Needle include 60mg/bottle, 80mg/bottle, 100mg/bottle, 110mg/bottle, 120mg/bottle, and 130mg/bottle, enhancing the product range [1] - Four Seasons Pharmaceutical is the only company in China to hold compliant products in both "少女针" (Girl Needle) and "童颜针" (Tongyan Needle), along with other significant medical aesthetic products such as botulinum toxin, water light needle, and golden microneedle [1] Group 2: Market Performance - The sales of the new regenerative products, Tongyan Needle and Girl Needle, have exceeded expectations, with institutions actively purchasing [2] - The medical aesthetic business is expected to continue its rapid growth due to the synergy of multiple products and integrated solutions aimed at medical aesthetic institutions [2] Group 3: Investment Outlook - Citic Securities maintains a "Buy" rating for Four Seasons Pharmaceutical, setting a target price of 1.6 HKD [2]

Group 1 - The core point of the news is that Sihuan Pharmaceutical (0460.HK) has received approval from the National Medical Products Administration of China for six new specifications of its self-developed polylactic acid facial filler, known as "Tongyan Needle," which enhances its market position in the regenerative medical aesthetics sector [1][2] - The newly approved specifications include 60mg/bottle, 80mg/bottle, 100mg/bottle, 110mg/bottle, 120mg/bottle, and 130mg/bottle, which will enrich the product selection [1] - Sihuan Pharmaceutical is the only domestic company holding compliant "Tongyan Needle" and "Shaonv Needle" regenerative filler products, along with other significant medical aesthetic devices such as botulinum toxin, hydrating needles, and golden micro-needles [2] Group 2 - The "Tongyan Needle" utilizes the core component of L-lactic acid (PLLA) microspheres, achieving both "immediate filling and long-lasting regeneration" effects, with patented technology ensuring uniform particle size and safety [2] - According to a report by CITIC Securities, Sihuan Pharmaceutical's botulinum toxin and other aesthetic products are experiencing rapid growth, with strong demand for the newly launched regenerative products [2] - The medical aesthetics business is expected to continue its rapid growth due to the synergy of multiple products and integrated solutions aimed at medical aesthetic institutions, with a maintained "buy" rating and a target price of 1.6 HKD [2]

Core Viewpoint - The rapid development of the medical beauty industry is accompanied by various malpractices, including false advertising, low-price traps, and illegal medical practices, prompting consumer protection agencies to issue warnings and guidelines for consumers [1][2]. Group 1: Industry Challenges - The medical beauty industry is experiencing a surge due to the "beauty economy," but it is also plagued by issues such as false advertising and low-price traps [1]. - Common tactics include exaggerated claims about doctor qualifications, fabricated celebrity endorsements, and misleading product effectiveness [1]. - Low-price promotions, such as "199 yuan water light needle" and "299 yuan double eyelid surgery," often lead to consumers facing significantly higher costs upon arrival at the clinic [1]. - Some institutions collaborate with financial platforms to offer "medical beauty loans" that appear attractive but hide high-interest rates and fees, leading to financial burdens for consumers [1]. Group 2: Consumer Protection Guidelines - The Xiamen Consumer Protection Committee has proposed five guidelines to help consumers avoid pitfalls in the medical beauty sector [3]. - Verify the qualifications of the medical institution, ensuring they possess the necessary licenses and that the performing physician is registered [3]. - Confirm the compliance of products used in procedures, checking for proper registration and labeling [3]. - Avoid impulsive purchases driven by marketing tactics, and make informed decisions based on personal needs and health [3]. - Sign formal contracts that clearly outline project details, costs, and guarantees, and retain all communication records [3]. - Steer clear of illegal medical beauty services, such as home visits or unlicensed private studios, which pose significant risks [3]. Group 3: Post-Procedure Actions - In cases of unsatisfactory results or physical harm post-procedure, consumers should retain evidence such as medical records and payment receipts [4]. - Initial communication with the medical beauty institution should focus on seeking repairs, refunds, or compensation, with all interactions documented [4]. - If negotiations fail, consumers can file complaints with relevant administrative departments or seek mediation through medical dispute committees [4].